ArticleInternal medicine (Tokyo, Japan)2019

Adrenomedullin: A Novel Therapy for Intractable Crohn's Disease with a Loss of Response to Infliximab.

Shinya Ashizuka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.